Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Zoetis (ZTS) to Acquire Nexvet Biopharma (NVET) for $6.72/Share
-
Zoetis to Acquire Nexvet Biopharma, an Innovator in Monoclonal Antibody Therapies for Companion Animals
-
Nexvet to Present at the Cowen and Company 37th Annual Health Care Conference
-
Nexvet to Present at the Cowen and Company 36th Annual Health Care Conference
-
Nexvet Biopharma (NVET) Provides Additional NV-01 Data at Investor Day; Cowen Reiterates Outperform
-
Nexvet Provides Speaker Update for Animal Health Symposium in New York City
-
Nexvet Provides Speaker Update for Animal Health Symposium in New York City
-
UPDATE: Cowen Starts Nexvet Biopharma (NVET) at Outperform; Drugs Have Animal Health 'Blockbuster Potential', Says Analyst
-
Nexvet Biopharma (NVET) Closes 4M Common IPO at $4/Share
-
Nexvet Biopharma Announces Closing of Initial Public Offering
-
Nexvet Biopharma (NVET) IPO Opens Down 9%
-
Nexvet Biopharma plc Announces Pricing of Initial Public Offering
-
Nexvet (NVET) Files $60M IPO

